Back to discover
Disease

Endotoxemia

Late-stage therapeutic developmentEmerging researchRising momentum
8
Publications
8
Clinical trials
2
Related conditions
2024
Latest publication
Current focus
Therapeutic developmentInflammation & immunityMetabolic & lifestyle factorsDisease mechanisms & pathology

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial with recent milestones.
Major developments
Major clinical milestoneWorth watching
Primary completion2025-09-01
Clinical Milestones1View

Clinical trials

3 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
8
All trials
1
Active
6
Late-stage
6
Completed
Late-stage studies
Recently completed

Research activity

8 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20092024
Most influential
Recent publications
Major themes8
  • Endotoxemia3
  • Disease Susceptibility1
  • Endotoxins1
  • Gastrointestinal Microbiome1
  • Insulin Resistance1
  • Metabolic Syndrome1
  • Neurodegenerative Diseases1
  • Norepinephrine1
Leading journals6
  • Gut2
  • International journal of molecular sciences2
  • Frontiers in immunology1
  • Journal of neuroinflammation1
  • Nature communications1
  • Nutrients1
Leading researchers8
  • Al-Abed Y1
  • Aliani M1
  • Anhê FF1
  • Beam A1
  • Cani PD1
  • Carone M1
  • Castellana G1
  • Castellaneta F1
Affiliations (unnormalised)6
  • Cardiology Axis of the Quebec Heart and Lung Institute1
  • Case Western Reserve University1
  • Center for Molecular Metabolism1
  • Donald & Barbara Zucker School of Medicine at Hofstra/Northwell1
  • Elmezzi Graduate School of Molecular Medicine1
  • Indiana University of Pennsylvania1

Related conditions

2 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Endotoxemia is a condition in which endotoxins are present in the bloodstream. In this grounding, it is described as arising when components of the outer cell wall of gram-negative bacteria enter systemic circulation and trigger a pro-inflammatory cascade.

Causes

The supplied material supports bacterial lysis or translocation of gram-negative bacterial endotoxin into the blood as the immediate cause. It also supports diet-induced metabolic endotoxemia, in which dietary alterations are associated with changes in gut microbiota and increased passage of lipopolysaccharide into the bloodstream.

Pathophysiology

Endotoxin in the blood initiates a pathophysiologic cascade of pro-inflammatory mediators. The reviews specifically describe lipopolysaccharide crossing a compromised intestinal barrier, activating Toll-like receptor 4, and driving production of pro-inflammatory cytokines that contribute to low-grade systemic inflammation.

Risk factors

Dietary patterns, especially Western and high-fat diets, are supported as factors associated with altered gut microbiota and metabolic endotoxemia. The abstracts also link obesity, diabetes, non-alcoholic fatty liver disease, and intestinal dysbiosis with increased gut permeability and endotoxin exposure.

AI-generated summary grounded in MeSH and 4 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.

Identifiers
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.